# American Journal of Transplantation

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/american-journal-of-transplantation/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 4,300 |
| Citations | 546,170 |
| h-index | 263 |
| Homepage | https://www.sciencedirect.com/journal/american-journal-of-transplantation |
| Open Access | false |
| ISSN-L | 1600-6135 |
| ISSNs | 1600-6135,1600-6143 |
| OpenAlex ID | https://openalex.org/S182625382 |
| Publisher | Elsevier BV |
| Works | 16,658 |

## Journal papers

Showing 12 of 122.

- [Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions](https://scholariq.org/papers/banff-07-classification-of-renal-allograft-pathology-updates-and-future/)
- [Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes](https://scholariq.org/papers/systematic-review-kidney-transplantation-compared-with-dialysis-in-clinically/)
- [Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients](https://scholariq.org/papers/special-issue-kdigo-clinical-practice-guideline-for-the-care-of-kidney/)
- [Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions](https://scholariq.org/papers/banff-2013-meeting-report-inclusion-of-c4d-negative-antibody-mediated-rejection/)
- [Diabetes Mellitus after Kidney Transplantation in the United States](https://scholariq.org/papers/diabetes-mellitus-after-kidney-transplantation-in-the-united-states/)
- [Antibody-Mediated Rejection Criteria - an Addition to the Banff ’97 Classification of Renal Allograft Rejection](https://scholariq.org/papers/antibody-mediated-rejection-criteria-an-addition-to-the-banff-97-classification/)
- [Cancer after Kidney Transplantation in the United States](https://scholariq.org/papers/cancer-after-kidney-transplantation-in-the-united-states/)
- [The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials](https://scholariq.org/papers/the-banff-2017-kidney-meeting-report-revised-diagnostic-criteria-for-chronic/)
- [COVID-19 in solid organ transplant recipients: Initial report from the US epicenter](https://scholariq.org/papers/covid-19-in-solid-organ-transplant-recipients-initial-report-from-the-us/)
- [The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection](https://scholariq.org/papers/the-banff-2019-kidney-meeting-report-i-updates-on-and-clarification-of-criteria/)
- [Identifying Specific Causes of Kidney Allograft Loss](https://scholariq.org/papers/identifying-specific-causes-of-kidney-allograft-loss/)
- [Evolution of Causes and Risk Factors for Mortality Post‐Liver Transplant: Results of the NIDDK Long‐Term Follow‐Up Study](https://scholariq.org/papers/evolution-of-causes-and-risk-factors-for-mortality-post-liver-transplant-results/)

## Journal top topics

Showing 8 of 25.

- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)
- [Organ Donation and Transplantation](https://scholariq.org/topics/organ-donation-and-transplantation/)
- [Transplantation: Methods and Outcomes](https://scholariq.org/topics/transplantation-methods-and-outcomes/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Renal and Vascular Pathologies](https://scholariq.org/topics/renal-and-vascular-pathologies/)
- [Cytomegalovirus and herpesvirus research](https://scholariq.org/topics/cytomegalovirus-and-herpesvirus-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.